Precision BioSciences Inc Cash Flow-to-Debt Ratio
Precision BioSciences Inc cash flow-to-debt ratio. Precision BioSciences Inc (DTIL) has a Cash Flow-to-Debt Ratio of -0.17x as of June 2026, meaning its operating cash flow of $-13.44 Million could theoretically repay 0% of its total liabilities ($80.63 Million) in one year. Check how high is Precision BioSciences Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Precision BioSciences Inc (2016–2025)
Cash flow-to-debt ratio of Precision BioSciences Inc from 2016 to 2025. Historical debt coverage capacity for Precision BioSciences Inc across 10 annual periods. Check Precision BioSciences Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Precision BioSciences Inc Cash Flow-to-Debt Ratio by Year (2016–2025)
Precision BioSciences Inc cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Precision BioSciences Inc. For the full cash flow conversion analysis, see Precision BioSciences Inc operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.06x | $-65.84 Million | $62.17 Million | ▼ -45.0% |
| 2024 | -0.73x | $-58.45 Million | $80.00 Million | ▼ -22.4% |
| 2023 | -0.60x | $-84.11 Million | $140.92 Million | ▼ -131.9% |
| 2022 | -0.26x | $-45.75 Million | $177.74 Million | ▼ -185.4% |
| 2021 | -0.09x | $-10.85 Million | $120.33 Million | ▲ +89.1% |
| 2020 | -0.83x | $-87.39 Million | $105.73 Million | ▼ -8.8% |
| 2019 | -0.76x | $-73.64 Million | $96.92 Million | ▼ -44.9% |
| 2018 | -0.52x | $-51.72 Million | $98.64 Million | ▼ -114.9% |
| 2017 | -0.24x | $-24.17 Million | $99.05 Million | ▼ -127.3% |
| 2016 | 0.89x | $92.27 Million | $103.16 Million | — |